{"id":9509,"date":"2026-04-17T13:30:30","date_gmt":"2026-04-17T05:30:30","guid":{"rendered":"https:\/\/chimebiologics.com\/?p=9509"},"modified":"2026-04-17T16:29:20","modified_gmt":"2026-04-17T08:29:20","slug":"from-china-bridging-biopharmaceutical-innovation-in-korea-chime-biologics-empowers-a-new-landscape-for-koreas-biopharma-industry","status":"publish","type":"post","link":"https:\/\/chimebiologics.com\/ja\/from-china-bridging-biopharmaceutical-innovation-in-korea-chime-biologics-empowers-a-new-landscape-for-koreas-biopharma-industry\/","title":{"rendered":"(English) From China, Bridging Biopharmaceutical Innovation in Korea - Chime Biologics Empowers a New Landscape for Korea's Biopharma Industry"},"content":{"rendered":"

\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000English<\/a>\u3068 \u4e2d\u6587<\/a>\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.<\/p>

<\/p>\n

From China, Bridging Biopharmaceutical Innovation in Korea<\/strong><\/h1>\n

\"\"<\/p>\n

Chime Biologics Empowers a New Landscape for Korea's Biopharma Industry<\/strong><\/h4>\n

Recently, the 2026 Hubei\u2013Korea Future Cooperation Exchange Event was successfully held in Wuhan, China. As an important platform for efficient collaboration between Chinese and Korean industries and capital, the event brought together government agencies, financial institutions, well-known enterprises, and industry representatives from both countries to conduct in-depth exchanges on strategic emerging industries, with a focus on biomedicine.<\/p>\n

During a panel discussion, Ms. Zhao Dandan, Director of Operation at Chime Biologics, shared insights and practical experiences on the synergistic development of the biopharmaceutical industries in China and Korea, highlighting Chime Biologics' unique value in the global biopharma supply chain.\"\"<\/p>\n

Korea's Biopharma Industry: From Rise to Upgrading<\/strong><\/h5>\n

Over the past decade, Korea has achieved rapid development in the field of large-molecule biologics.<\/p>\n

By initially leveraging the transfer of pharmaceutical manufacturing from Europe and the United States, Korea has transformed biologics CMC development and commercial production into a key high-tech national industry, giving rise to several large-scale CDMOs with global competitiveness.<\/p>\n

However, beneath this successful trajectory, structural challenges have gradually emerged:<\/p>\n